We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
145 hedge funds and large institutions have $153M invested in Anavex Life Sciences in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
66% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 29
36% more capital invested
Capital invested by funds: $113M → $153M (+$40.2M)
28% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 18
4% more funds holding
Funds holding: 140 → 145 (+5)
2% more call options, than puts
Call options by funds: $4.89M | Put options by funds: $4.79M
0.14% more ownership
Funds ownership: 31.67% → 31.82% (+0.14%)
Holders
145
Holders Change
+5
Holders Change %
+3.57%
% of All Funds
2.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
48
Reduced
29
Closed
18
Calls
$4.89M
Puts
$4.79M
Net Calls
+$94K
Net Calls Change
-$651K
Top Buyers
| 1 |
NL
NWAM LLC
Mercer Island,
Washington
|
+$5.25M |
| 2 |
BlackRock
New York
|
+$2.01M |
| 3 |
Millennium Management
New York
|
+$1.75M |
| 4 |
Morgan Stanley
New York
|
+$1.62M |
| 5 |
Goldman Sachs
New York
|
+$1.18M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$3.89M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.43M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.88M |
| 4 |
Renaissance Technologies
New York
|
-$1.28M |
| 5 |
Two Sigma Investments
New York
|
-$1.05M |
